{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:46:18Z","timestamp":1792183578157,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003410.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T00:00:00Z","timestamp":1323216000000}}],"reference-count":71,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003410.pub4","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T20:46:42Z","timestamp":1323118002000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Heroin maintenance for chronic heroin-dependent individuals"],"prefix":"10.1002","volume":"2012","author":[{"given":"Marica","family":"Ferri","sequence":"first","affiliation":[{"name":"European Monitoring Centre for Drugs and Drug Addiction; Interventions, Best Practice and Scientific Partners; Cais do Sodre' 1249-289 Lisbon Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Davoli","sequence":"additional","affiliation":[{"name":"Lazio Regional Health Service; Department of Epidemiology; Via di Santa Costanza, 53 Rome Italy 00199"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo A.","family":"Perucci","sequence":"additional","affiliation":[{"name":"ASL RM\/E; Department of Epidemiology; Via di Santa Costanza, 53 Rome Italy 00198"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,12,7]]},"reference":[{"key":"10.1002\/14651858.CD003410.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/bmj.327.7410.310","article-title":"Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials","volume":"327","author":"Brink","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD003410.pub4-BIB0002|cit2","first-page":"108","article-title":"Dutch research on the effectiveness of medical prescription of heroin; background, research design and preliminary results","volume":"144","author":"Brink","year":"2000","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"3","key":"10.1002\/14651858.CD003410.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/002204269902900309","article-title":"Medical co-prescription of heroin to chronic, treatment-resistant methadone patients in the Netherlands","volume":"29","author":"Brink","year":"1999","journal-title":"Journal of Drug Issues"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0004|cit4","unstructured":"van den Brink Wim Hendriks VM Blanken P Huijsman IA van Ree JM Medical Co-prescription of Heroin. Two trials Central Committee on the treatment of heroin addicts - The Netherlands 2002"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/bmj.327.7410.310","article-title":"Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials","volume":"327","author":"Brink","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0006|cit6","volume-title":"Medical co-prescription of Heroin. Two trials","author":"Brink","year":"2002"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1192\/bjp.bp.106.026112","article-title":"Heroin-assisted treatment for opioid dependence. Randomised controlled trial","volume":"191","author":"Haasen","year":"2007","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003410.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10979-008-9138-8","article-title":"Explaining the effectiveness of heroin-assisted treatment on crime reductions","volume":"33","author":"L\u00f6bmann","year":"2009","journal-title":"Law Hum Behav"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/archpsyc.1980.01780210035003","article-title":"Evaluation of heroin maintenance in controlled trial","volume":"37","author":"Hartnoll","year":"1980","journal-title":"Archives of General Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD003410.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus methadone for the treatment of opioid addiction","volume":"361","author":"Oviedo-Joekes","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003410.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jsat.2006.04.007","article-title":"Controlled trial of prescribed heroin in the treatment of opioid addiction.","volume":"31","author":"March","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1745-6215-10-70","article-title":"Efficacy of prescribed injectable diacetylmorphine in the Andalusian trial: Bayesian analysis of responders and non-responders according to a multi domain outcome index","volume":"10","author":"Perea-Milla","year":"2009","journal-title":"Trials"},{"issue":"7150","key":"10.1002\/14651858.CD003410.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.317.7150.13","article-title":"Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments","volume":"317","author":"Perneger","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1477-7517-3-28","article-title":"Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK","volume":"3","author":"Nicholas","year":"2006","journal-title":"Harm Reduction Journal"},{"issue":"9729","key":"10.1002\/14651858.CD003410.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(10)60349-2","article-title":"Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial.","volume":"375","author":"Strang","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0016|cit16","first-page":"35","article-title":"Horse trading: Prescribing Injectable Opiates to Opiate Addicts - A descriptive study","volume":"7","author":"Battersby","year":"1992","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD003410.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1360-0443.1999.9422317.x","article-title":"Comparison of methadone and slow release morphine maintenance in pregnant addicts","volume":"94","author":"Fischer","year":"1999","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/bmj.300.6726.719-a","article-title":"Comparison of oral preparations of heroin and methadone to stabilise opiate misusers as inpatients","volume":"300","author":"Ghodse","year":"1990","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003410.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/02791072.2001.10400475","article-title":"Effects of High-Dose Heroin vs Morphine in Intravenous Drug Users: a Randomised Double-Blind Crossover Study","volume":"33","author":"Haemmig","year":"2001","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0924-977X(01)00091-8","article-title":"Heroin self-administration by means of 'chasing the dragon?: pharmacodynamics and bioavailability of inhaled heroin","volume":"11","author":"Hendriks","year":"2001","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0376-8716(86)90079-7","article-title":"Comparison of intravenously administered methadone, morphine and heroin","volume":"17","author":"Jasinnski","year":"1986","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD003410.pub4-BIB0022|cit22","first-page":"171","article-title":"Medically indicated heroin prescription in the treatment of drug addicts","volume":"45","author":"Krausz","year":"1999","journal-title":"Sucht"},{"issue":"6","key":"10.1002\/14651858.CD003410.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0740-5472(96)00155-9","article-title":"Prescribing drug of choice to illicit heroin users: the experience of a U.K. community drug team","volume":"13","author":"McCusker","year":"1996","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1002\/14651858.CD003410.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-3565(25)32374-8","article-title":"Operant analysis of human heroin self-administration and the effects of Naltrexone","volume":"216","author":"Mello","year":"1981","journal-title":"The journal of pharmacology and experimental therapeutics"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5694\/j.1326-5377.1998.tb141444.x","article-title":"Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions","volume":"168","author":"Metrebian","year":"1998","journal-title":"Medical Journal of Australia"},{"issue":"8","key":"10.1002\/14651858.CD003410.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1360-0443.2004.00764.x","article-title":"Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opiod dependence","volume":"99","author":"Mitchell","year":"2004","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000259134","article-title":"Morphine maintenance treatment of opioid-dependent out-patients","volume":"2","author":"Moldovany","year":"1996","journal-title":"European Addiction Research"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0376-8716(82)90061-8","article-title":"Seven year follow-up of heroin addicts: life history summarised","volume":"9","author":"Oppenheimer","year":"1982","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(01)06529-1","article-title":"Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts : a follow-up study","volume":"358","author":"Rehm","year":"2001","journal-title":"The Lancet"},{"issue":"11","key":"10.1002\/14651858.CD003410.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1046\/j.1360-0443.2000.951116314.x","article-title":"Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome","volume":"95","author":"Strang","year":"2000","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0031|cit31","doi-asserted-by":"crossref","DOI":"10.1159\/isbn.978-3-318-00369-7","volume-title":"Prescription of Narcotics for Heroin Addicts","volume":"1","author":"Uchtnehagen","year":"1999"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0032|cit32","unstructured":"Projet pilote de traitement assist\u00e9 par diac\u00e9tylmorphine: comparaison entre un traitement par diac\u00e9tylmorphine et un traitement par m\u00e9thadone. Ongoing study"},{"issue":"5418","key":"10.1002\/14651858.CD003410.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1126\/science.284.5418.1277","article-title":"The heroin prescribing debate: integrating science and politics","volume":"284","author":"Bammer","year":"1999","journal-title":"Science"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0034|cit34","unstructured":"CONSORT group How\u00a0CONSORT began CONSORT-Statement.org URL: http:\/\/www.consort-statement.org\/about-consort\/history\/"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0035|cit35","article-title":"Health Regional Plan 2000-2","volume-title":"Piano Sanitario Regionale triennio 2000-2","author":"Davoli","year":"2000"},{"issue":"4","key":"10.1002\/14651858.CD003410.pub4-BIB0036|cit36","first-page":"1297\u2013300","article-title":"Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials","volume":"330","author":"Dijkgraaf","year":"2005","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0037|cit37","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association (Pub.)","year":"1994"},{"issue":"3","key":"10.1002\/14651858.CD003410.pub4-BIB0038|cit38","article-title":"Effects of drug substitution programs on offending among drug-addicts","author":"Egli","year":"2009","journal-title":"Campbell Systematic Reviews"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0039|cit39","volume-title":"Guidelines for Estimating the Incidence ofProblem Drug Use","author":"Scalia Tomba","year":"2008"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0040|cit40","volume-title":"Annual report on the state of the drugs problem in Europe","author":"EMCDDA","year":"2009"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0041|cit41","article-title":"Trends in injecting drug use in Europe","volume-title":"Selected Issue","author":"EMCDDA","year":"2010"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0042|cit42","article-title":"Treatment and care for older drug users","volume-title":"Selected Issue","author":"EMCDDA","year":"2010"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0043|cit43","first-page":"386","article-title":"Psychoeducation as a method in addiction services. In Practice, Legislation and Policy on Drugs","volume-title":"Drogenpraxis Drogenrecht Drogenpolitik","author":"Farnbacher","year":"2002"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/bmj.309.6960.997","article-title":"Fortnightly Review: Methadone maintenance treatment in opiate dependence: a review","volume":"309","author":"Farrell","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bmj.316.7132.639","article-title":"The Swiss heroin trials: testing alternative approaches","volume":"316","author":"Farrell","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0376-8716(95)01205-2","article-title":"Heroin addicts and methadone treatment in Albuquerque: a 22 year follow-up","volume":"40","author":"Goldstein","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0047|cit47","doi-asserted-by":"crossref","DOI":"10.1159\/isbn.978-3-318-00432-8","volume-title":"Cost-benefit analysis of heroin maintenance treatment. Medicalprescription of narcotics.","volume":"2","author":"Gutzwiller","year":"2000"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0048|cit48","first-page":"124\u201330","article-title":"Is Heroin-Assisted Treatment Effective for Patientswith No Previous Maintenance Treatment? Resultsfrom a German Randomised Controlled Trial","volume":"16","author":"C. Haasen U. Verthein F.J. Eiroa-Orosa I. Sch\u00e4fer J.","year":"2010","journal-title":"European Addiction Research"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0049|cit49","unstructured":"Hartnoll Richard Heroin Prescription and public health research. Epidemiological problems Abstract book. International Symposium: heroin assisted treatment for dependent drug users. University of Bern, Switzerland 10-12 March 1999 1999"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0050|cit50","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2009] The Cochrane Collaboration Available from www.cochrane-handbook.org. September 2008","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archpsyc.1993.01820190079008","article-title":"A 24-follow-up of California narcotic addicts","volume":"50","author":"Hser","year":"1993","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0052|cit52","volume-title":"Basic and Clinical Pharmacology","author":"Katzung","year":"1999"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000259089","article-title":"EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence","volume":"1","author":"Kokkevi","year":"1995","journal-title":"European Addiction Research"},{"issue":"3","key":"10.1002\/14651858.CD003410.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The Fifth Edition of the Addiction Severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"J Subst Abuse Treat"},{"issue":"13","key":"10.1002\/14651858.CD003410.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug Dependence, a Chronic Medical Illness. Implications for Treatment, Insurance, and Outcomes Evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"Journal of American Medical Association"},{"issue":"5335","key":"10.1002\/14651858.CD003410.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.278.5335.66","article-title":"A range of research-based pharmacotherapies for addiction","volume":"278","author":"O'Brien","year":"1997","journal-title":"Science"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0057|cit57","volume-title":"Case Management in der Suchtkranken- und Drogenhilfe","author":"Oliva","year":"2001"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0058|cit58","unstructured":"The Nordic Cochrane Centre Review Manager 2008"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0059|cit59","volume-title":"Rolleston Report of the Departmental Committee on Morphine and Heroin Addiction","author":"Departmental Committee on Morphine and Heroin Addiction","year":"1926"},{"issue":"52","key":"10.1002\/14651858.CD003410.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0895-4356(99)00009-8","article-title":"The Zelen design may be the best choice for a heroin-provision experiment","volume":"6","author":"Schellings","year":"1999","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0061|cit61","first-page":"192","article-title":"Prescribing Heroin and other Injectable Drugs","volume-title":"Heroin Addiction and Drug Policy The British System","author":"Strang","year":"1994"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0062|cit62","volume-title":"World Drug Report","author":"United Nations Office on Drugs and Crime","year":"2007"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0063|cit63","volume-title":"2010 Report: Promoting health,security and justice","author":"UNODC","year":"2010"},{"issue":"3","key":"10.1002\/14651858.CD003410.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/002204269902900309","article-title":"Medical co-prescription of heroin to chronic treatment-resistant methadone patients in The Netherlands","volume":"29","author":"Brink","year":"1999","journal-title":"Journal of Drug Issues"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/bmj.317.7164.1011","article-title":"Trial is needed comparing decriminalisation of heroin with existing policy of prohibition","volume":"317","author":"Venning","year":"1998","journal-title":"BMJ"},{"issue":"9148","key":"10.1002\/14651858.CD003410.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","article-title":"Role of maintenance treatment in opioid dependence","volume":"353","author":"Ward","year":"1999","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0067|cit67","volume-title":"From chocolate to morphine","author":"Weil","year":"1998"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0068|cit68","volume-title":"World Drug Report 28th","volume":"836","author":"WHO Expert Committee on Drug Dependence","year":"1997"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0069|cit69","volume-title":"Guidelines for the PsychosociallyAssisted Pharmacological Treatmentof Opioid Dependence","author":"WHO","year":"2009"},{"key":"10.1002\/14651858.CD003410.pub4-BIB0070|cit70","first-page":"1011","article-title":"Further studies of heroin treatment are needed","volume":"317","author":"Wodak","year":"1998","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003410.pub4-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003410.pub2","article-title":"Heroin maintenance for chronic heroin dependents","author":"Ferri","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003410.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T22:33:19Z","timestamp":1741991599000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003410.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,7]]},"references-count":71,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003410.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,7]]}}}